灯盏细辛注射液临床应用调查问卷分析及医保患者临床用药建议

目的为了规范医疗保险住院患者灯盏细辛注射液的临床应用,为制订北京市医疗保险政策提供依据,对灯盏细辛注射液的临床应用进行问卷调查,参考调查结果提出临床用药建议。方法选取20家医保定点医院,对350名医生进行问卷调查,对采集的数据进行统计分析。结果被调查医生94.7%、70.3%、63.4%认为灯盏细辛注射液对缺血性脑卒中、冠心病、心绞痛有效,76%的医生选择了每次90～180mg,每日1次,静脉注射的给药方案,76.4%的医生认为每疗程14d为宜,认为灯盏细辛注射液使用较安全的占78.5%。结论建议灯盏细辛注射液用于脑梗塞、冠心病不稳定心绞痛、急性心肌梗死,每次90～180mg,每日1次,静脉注射给药,14d为一疗程。

Analysis of questionare about medication Use of Dengzhan Xixin Injection and proposal for clinic application

Objective To regulate Dengzhan Xixin Injection medication use application, and make reference for management of Medical Insurance, the questionare about Dengzhan Xixin Injection application was sent, the Results was used in tabling proposals. Methods 20 hospitals Of Medical Insurence were selected, the questionare were given to 350 doctors, the data were statisticed. Results 94.7%, 70.3%, 63.4% of the doctors considered that Dengzhan Xixin injection was effected to anhemonic stroke, coronary heart disease, heart angina; 76% agree that it should be given 90-180mg, one time a day; 76.4% approve that the course of treatment was 14 days, Conclusion The the applications of Dengzhan Xixin Injection were suggested to be brain infarct, heart angina and infarct, it should be injected intravenous 90-180mg one time a day, 14 days for one treatment course.